Oral contraceptives and menopausal hormone therapy as breast cancer risk categories

Author:

Vуsotskaya I. V.1ORCID,Letyagin V. P.2ORCID,Vorotnikov I. K.2ORCID,Kirsanov V. U.1ORCID,Gladilina I. A.2ORCID,Kim E. A.2ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

2. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Abstract

The research provided includes analysis of the current state of the problem on the use of oral contraceptives and menopausal hormone therapy. These therapeutic options were evaluated in terms of their importance for the risk of breast cancer. The possibility of using these drugs in a cohort of high-risk patients (women with family history of breast cancer) and in the group of patients with benign pathology was analyzed as well. Modern trends of menopausal hormone therapy prescription in different clinical situations were determined.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Obstetrics and Gynaecology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference41 articles.

1. Vessey M., Yeates D. Oral contraceptives and bening breast disease: an update of finding in a large cohort study. Contraception 2007;76(6):418–24. DOI: 10.1016/j.contraception.2007.08.011.

2. Cibula D., Gompel A., Mueck A.O. et al. Hormonal contraception and risk of cancer. Hum Reprod Upd 2010;6(16):631–50. DOI: 10.1093/humupd/dmq022.

3. Savel’eva I.S. The effect of hormonal contraceptives on the risk of developing breast cancer. Ginekologiya = Gynecology 1999;1(1). (In Russ.)

4. Ul’rikh E.A., Kutusheva G.F., Urmancheeva A.F. Oncological aspects of contraception. Prakticheskaya onkologiya = Practical Oncology 2009;10(4):254–64. (In Russ.)

5. Prokop’eva T.A., Gorbunova E.E. Hormone replacement therapy and breast cancer. Prakticheskaya meditsina = Practical Medicine 2011;6(54):23–8. (In Russ.)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3